Stock listing
Acadia Pharmaceuticals Inc.
Selected listing: 603035 · LS · EUR · DE
Acadia Pharmaceuticals Inc. (Lang & Schwarz: 603035), Health Technology. Latest release Sep 28, 2026: Acadia Pharmaceuticals Announces Allowance of U.S.…
- Ticker
- Lang & Schwarz: 603035
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Acadia Pharmaceuticals Inc.
The company focuses on developing innovative therapies for central nervous system disorders. Acadia is committed to advancing its pipeline to address unmet medical needs in this area.
Latest news from Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
September 28, 2026
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
September 24, 2026
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
August 24, 2026
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 4, 2026
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 30, 2026
Events
Research Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. company profile
View the public company page for Acadia Pharmaceuticals Inc. on 6ix.
Acadia Pharmaceuticals Inc. news
Read company news and market updates connected to Acadia Pharmaceuticals Inc..
Acadia Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Acadia Pharmaceuticals Inc..
Alternate listings
ACAD:NASDAQ
US · USD
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:GETTEX
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:TRADEGATE
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
ACAD:BMV
MX · MXN
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
603035:LSX
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:FWB
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
ACAD:BIVA
MX · MXN
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
ACAD:BOATS
US · USD
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
0A4W:LSE
GB · USD
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:DUS
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:MUN
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.
DR6:SWB
DE · EUR
Alternate listing for Acadia Pharmaceuticals Inc.; the primary context on this page is 603035:LS.